Ferozsons (Lab) (FEROZ) Stock Price and Company Financials
Rs. 325.07
Rs. 2.32 (0.71%)
Last updated: 2026-09-28
Annual Financials (Latest Year: 2025)
SalesRs. 13,857,967,000
Total revenue generated from core business operations during the year.
Profit After TaxRs. 528,243,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)Rs. 12.15
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin41.27%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin3.81%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth32.07%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.
Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.
*Annual figures from latest financial statement
| Open | Close | Low | High | Volume |
|---|---|---|---|---|
| 327.39 | 325.07 | 322.84 | 327.50 | 6,235 |